Two new papers were published by the ISOLPHARM collaboration in July 2025. Both articles belong to the WP4 activities of the ADMIRAL experiment, dealing with radiobiology and radiation biophysics. The first one, entitled “Monte Carlo dosimetry of silver-111 in simplified cell geometries in the framework of the ISOLPHARM project” and published by the journal Applied…
Read more
In October 2024, the ISOLPHARM collaboration successfully performed the first clonogenic survival evaluation using silver-111 on cancer cells. In particular, the UMR-106 rat osteosarcoma cell line was tested. This result represents a first important experimental milestone reached by the ISOLPHARM radiobiology community, which includes groups from the Universities of Pavia (with the LENA facility), Padova,…
Read more
Four master students of the Department of Physics and Astronomy of the University of Padova graduated in September with theses projects developed within the ISOLPHARM project. Nicola Zancopè analyzed and interpreted CLI and DRI images in view of a Ag-111 biodistribution experiment. Vittoria Pavanello studied the performance of the novel 2D imaging beta detector of…
Read more
ISOLPHARM earned a Special Mention at the 108th Congress of the Italian Physical Society (SIF) thanks to the communication “Radiobiological model for β-emitter radiopharmaceutical therapy in dynamic cell cultures in the framework of the ISOLPHARM project”, presented by Alberto Arzenton. The contribution, that was included in the Biophysics and Medical Physics section, has been published…
Read more
